Renaissance Technologies
BMRA icon

Renaissance Technologies’s Biomerica BMRA Stock Holding History

Renaissance Technologies’s Portfolio BMRA Stock Details BMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,500
Closed -$153K – 3465
2021
Q1 		$153K Sell
3,500
-1,735
-33% -$88.9K ﹤0.01% 3183
2020
Q4 		$209K Buy
+5,235
New +$262K ﹤0.01% 3120

Other funds holding BMRA

GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FC
Fore Capital New York $338M AUM 10.07% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HIMC
Heritage Investors Management Corp Bethesda, Maryland $3.61B AUM 35.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Renaissance Technologies's BMRA Position: Q2 2021 in Review

Renaissance Technologies sold out of Biomerica (BMRA) in Q2 2021, closing a stake of 3,500 shares — an estimated $153K sold.

Renaissance Technologies first reported a position in BMRA in Q4 2020 and held it in 2 quarters. The position peaked at $209K in Q4 2020. 26 funds tracked by Wall St. Rank hold BMRA as of Q2 2021.

  • Renaissance Technologies reported no remaining Biomerica position as of Q2 2021 after selling out during the quarter.
  • Renaissance Technologies sold 3,500 Biomerica shares in Q2 2021, an estimated $153K.
  • Renaissance Technologies first reported a position in Biomerica in Q4 2020 and held it in 2 quarters.
  • Renaissance Technologies's Biomerica position peaked at $209K in Q4 2020.
  • 26 funds tracked by Wall St. Rank held Biomerica as of Q2 2021.

Based on Renaissance Technologies's 13F filing for Q2 2021, filed 13 Aug 2021.